Financhill
Sell
17

DGICA Quote, Financials, Valuation and Earnings

Last price:
$15.57
Seasonality move :
-3.69%
Day range:
$15.51 - $15.81
52-week range:
$12.26 - $17.00
Dividend yield:
4.41%
P/E ratio:
20.51x
P/S ratio:
0.53x
P/B ratio:
1.03x
Volume:
168K
Avg. volume:
130.1K
1-year change:
12.4%
Market cap:
$528.4M
Revenue:
$927.3M
EPS (TTM):
$0.76

Earnings Data

Next earnings date for DGICA
Feb 21
2025
Most recent earnings per share
$0.51
Beat by $0.43
(Oct 24/2024)
Consensus Estimate
$0.08
(Oct 24/2024)

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

DGICA Quarterly Earnings History

Date Quarter Revenue Forecast Actual Revenue Reported EPS Consensus EPS Beat/Miss
02/21/2025 Q4 $250.6M -- -- $0.26 --
10/24/2024 Q3 $249.6M $251.7M $0.51 $0.08 $0.43
07/25/2024 Q2 $241.9M $246.8M $0.13 $0.09 $0.05
04/25/2024 Q1 $236.6M $241.1M $0.18 $0.25 -$0.07
02/22/2024 Q4 $234M $239.5M -$0.06 $0.22 -$0.28
10/26/2023 Q3 -- -- -$0.02 $0.01 -$0.03
07/27/2023 Q2 -- -- $0.06 $0.19 -$0.13
04/27/2023 Q1 -- -- $0.16 $0.35 -$0.19
02/23/2023 Q4 -- -- $0.11 $0.29 -$0.18
10/27/2022 Q3 -- -- -$0.33 $0.33 -$0.66
07/28/2022 Q2 -- -- -$0.26 $0.38 -$0.64
04/28/2022 Q1 -- -- $0.42 $0.23 $0.19
02/17/2022 Q4 -- -- $0.17 $0.38 -$0.21
10/27/2021 Q3 -- -- -$0.22 $0.15 -$0.37
07/27/2021 Q2 -- -- $0.53 $0.25 $0.29
04/26/2021 Q1 -- -- $0.35 $0.36 -$0.01
02/23/2021 Q4 -- -- $0.49 $0.32 $0.17
10/28/2020 Q3 -- -- $0.41 $0.19 $0.22
07/27/2020 Q2 -- -- $0.79 $0.27 $0.53
04/28/2020 Q1 -- -- $0.12 $0.28 -$0.16
02/24/2020 Q4 -- -- $0.45 $0.26 $0.19
10/30/2019 Q3 -- -- $0.16 $0.16 $0.01
07/29/2019 Q2 -- -- -- $0.04 --
04/30/2019 Q1 -- -- -- $0.09 --
02/19/2019 Q4 -- -- -- -$0.31 --
10/30/2018 Q3 -- -- -- $0.07 --
07/30/2018 Q2 -- -- -- -- --
04/23/2018 Q1 -- -- -- -- --
02/23/2018 Q4 -- -- -- -- --
10/30/2017 Q3 -- -- -- -- --
07/19/2017 Q2 -- -- -- -- --
04/19/2017 Q1 -- -- -- -- --
02/17/2017 Q4 -- -- -- -- --
10/28/2016 Q3 -- -- -- -- --
07/26/2016 Q2 -- -- -- -- --
04/20/2016 Q1 -- -- -- -- --
02/19/2016 Q4 -- -- -- -- --
10/24/2015 Q3 -- -- -- -- --
07/28/2015 Q2 -- -- -- -- --
04/24/2015 Q1 -- -- -- -- --
02/20/2015 Q4 -- -- -- -- --

Donegal Group Earnings Questions

  • How Much did Donegal Group Generate in Revenue Last Quarter?

    Donegal Group reported $251.7M worth of top line sales in its most recent quarter.

  • Did Donegal Group Beat Earnings Last Quarter?

    Donegal Group announced earnings per share of $0.51 which represents a beat of analyst forecast a $0.08 per share.

  • Is Donegal Group Profitable?

    Donegal Group reported -- that represents -- per share over the last quarter.

  • What is the Analyst Consensus for Donegal Group EPS Next Year?

    Donegal Group's earnings are forecast to grow from $0.14 per share to $0.41 per share next year representing an increase of 578.57%.

  • When is Donegal Group's Earnings Date?

    Donegal Group's next earnings date is February 21, 2025.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Why Caesars’ Digital Arm May Be the Gaming Giant’s Best-Kept Secret
Why Caesars’ Digital Arm May Be the Gaming Giant’s Best-Kept Secret

It’s not often that a company with the scale and…

Will Tyson Foods Stock Bounce Back?
Will Tyson Foods Stock Bounce Back?

Tyson Foods, Inc. (NYSE:TSN) is one of the biggest food…

Will Iovance Biotherapeutics Stock Bounce Back?
Will Iovance Biotherapeutics Stock Bounce Back?

Iovance Biotherapeutics (NASDAQ:IOVA) is a fledgling pharmaceutical company that specializes…

Stock Ideas

Buy
64
Is AAPL Stock a Buy?

Market Cap: $3.8T
P/E Ratio: 42x

Buy
52
Is NVDA Stock a Buy?

Market Cap: $3.3T
P/E Ratio: 113x

Buy
55
Is MSFT Stock a Buy?

Market Cap: $3.2T
P/E Ratio: 37x

Alerts

Buy
61
QMCO alert for Dec 21

Quantum [QMCO] is up 26.28% over the past day.

Sell
46
NUKK alert for Dec 21

Nukkleus [NUKK] is down 22.94% over the past day.

Sell
1
IIPR alert for Dec 21

Innovative Industrial Properties [IIPR] is down 22.7% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock